Prevention of sarcopenia by biologic agents and JAK inhibitors in rheumatoid arthritis; PRESENT study
Phase 4
Recruiting
- Conditions
- Rheumatoid arthritis, Sarcopenia
- Registration Number
- JPRN-UMIN000037797
- Lead Sponsor
- Department of Orthopaedic surgery, Osaka City General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.Complicated with sever complication patients 2.Autoimmune disease patients effected inflammation except rheumatoid arthritis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method